HOWLAND CAPITAL MANAGEMENT LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1079112 BOSTON, MA

Position in VRTX

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$982,035

+$100,119 QoQ

Shares Held

1,977

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#860

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 60% Shared 0% None 40%

Healthcare · as of Jun 30, 2026

HOWLAND CAPITAL MANAGEMENT LLC holds $26,069,769 across 4 Biotechnology names. VRTX ranks #3 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	37,174	$23,179,475
2	ALNY	Alnylam Pharmaceuticals, Inc.	4,534	$1,364,870
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,977	$982,035
4	AXSM	Axsome Therapeutics, Inc.	2,220	$543,389

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$982,035	1,977	+0.1%	Shares	Sole	2026-07-13
2026-03-31	$881,916	1,975	+5.1%	Shares	Sole	2026-04-14
2025-12-31	$851,863	1,879	-2.0%	Shares	Sole	2026-02-13
2025-09-30	$751,165	1,918	+8.0%	Shares	Sole	2025-10-29
2025-06-30	$790,675	1,776	-10.1%	Shares	Sole	2025-08-15
2025-03-31	$957,519	1,975	+14.5%	Shares	Sole	2025-05-08
2024-12-31	$694,657	1,725	+2.3%	Shares	Sole	2025-01-28
2024-09-30	$784,124	1,686	+13.2%	Shares	Sole	2024-11-12
2024-06-30	$697,924	1,489	+78.1%	Shares	Sole	2024-08-12
2024-03-31	$349,456	836	-14.1%	Shares	Sole	2024-05-03
2023-12-31	$395,903	973	-4.7%	Shares	Sole	2024-01-23
2023-09-30	$355,042	1,021	-10.9%	Shares	Sole	2023-10-17
2023-06-30	$403,288	1,146	0.0%	Shares	Sole	2023-07-28
2023-03-31	$361,070	1,146	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.